CARIBOU BIOSCIENCES ($CRBU) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of -$0.24 per share, beating estimates of -$0.32 by $0.08. The company also reported revenue of $1,500,000, missing estimates of $2,324,580 by $-824,580.
You can see Quiver Quantitative's $CRBU stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CARIBOU BIOSCIENCES Insider Trading Activity
CARIBOU BIOSCIENCES insiders have traded $CRBU stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CRBU stock by insiders over the last 6 months:
- BARBARA G MCCLUNG (Chief Legal Officer) sold 6,938 shares for an estimated $13,598
- RUHI AHMAD KHAN (Chief Business Officer) sold 6,938 shares for an estimated $13,598
- TIMOTHY P KELLY (Chief Technology Officer) sold 3,147 shares for an estimated $6,168
- TINA M. ALBERTSON (Chief Medical Officer) sold 1,066 shares for an estimated $2,089
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CARIBOU BIOSCIENCES Hedge Fund Activity
We have seen 66 institutional investors add shares of CARIBOU BIOSCIENCES stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 5,672,758 shares (+264.7%) to their portfolio in Q2 2026, for an estimated $9,984,054
- MACKENZIE FINANCIAL CORP added 2,708,010 shares (+287.2%) to their portfolio in Q2 2026, for an estimated $4,766,097
- GEODE CAPITAL MANAGEMENT, LLC added 1,356,935 shares (+133.3%) to their portfolio in Q2 2026, for an estimated $2,388,205
- ABERDEEN GROUP PLC removed 1,212,541 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,134,072
- STATE STREET CORP added 1,209,651 shares (+285.8%) to their portfolio in Q2 2026, for an estimated $2,128,985
- ACADIAN ASSET MANAGEMENT LLC added 849,435 shares (+91.8%) to their portfolio in Q2 2026, for an estimated $1,495,005
- MARSHALL WACE, LLP removed 829,982 shares (-68.8%) from their portfolio in Q2 2026, for an estimated $1,460,768
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CARIBOU BIOSCIENCES Price Targets
Multiple analysts have issued price targets for $CRBU recently. We have seen 2 analysts offer price targets for $CRBU in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $11.0 on 05/11/2026
- Jonathan Miller from Evercore ISI Group set a target price of $13.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
